Article Details

Chinese Drug Developer I-Mab Proceeds With Shanghai Dual Listing

Retrieved on: 2021-07-28 05:25:17

Tags for this article:

Click the tags to see associated articles and topics

Chinese Drug Developer I-Mab Proceeds With Shanghai Dual Listing. View article details on hiswai:

Excerpt

The stock wasn't spared in the recent rout in U.S.-listed Chinese companies as investors shunned the assets amid a broad-based crackdown by ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up